Review and evaluate the role of a psychiatric pharmacist on medication management in a Gender Health Program

被引:2
|
作者
Wartman, Carolanne [1 ,2 ]
Walroth, Todd A. [1 ,2 ]
Butterfield, David [1 ,2 ]
Anderson, Lindsey [1 ,2 ]
Peters, Michael [1 ]
Schmelz, Andrew [1 ,3 ]
Ott, Carol [1 ,2 ,4 ]
机构
[1] Eskenazi Hlth, Dept Pharm, Indianapolis, IN 46202 USA
[2] Purdue Univ, Coll Pharm, Dept Pharm Practice, W Lafayette, IN 47907 USA
[3] Butler Univ, Dept Pharm Practice, Coll Pharm, Indianapolis, IN 46208 USA
[4] Indiana Univ Sch Med, Dept Psychiat, Indianapolis, IN 46202 USA
来源
JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY | 2022年 / 5卷 / 12期
关键词
mental health; pharmacists; psychiatry; transgender persons;
D O I
10.1002/jac5.1722
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction People who identify as transgender experience a significant amount of mental health concerns compared to the general population. Gender health programs offer the opportunity to provide comprehensive care for this highly stigmatized population, with the potential for psychiatric pharmacists to assist other providers and serve this need. This study aimed to evaluate the number and type of interventions made by a psychiatric pharmacist within a Gender Health Program. Methods A retrospective review of the electronic medical record was conducted analyzing mental health visits completed by psychiatric pharmacists within the Gender Health Program between May 1, 2020 and December 31, 2021. The primary outcome was number and type of interventions, defined as medication adjustments, laboratory monitoring, and completion of prior authorizations. Secondary outcomes included a description of medication regimens, number and type of patient education provided, and referrals to other healthcare professionals. Key subgroup analyses consisted of number of interventions based on gender identity, race identity, and insurance status. Results There were a total of 152 appointments among 93 patients. Sixty-one patients (66%) received at least one intervention [median (interquartile range, IQR) of 2 (2, 4)], which occurred across 81 pharmacist appointments (53%). Psychotropic medications were adjusted at 79 appointments (97%), with primarily medication initiations. Patient education was completed and documented at 102 appointments with a median (IQR) of 2 (1, 2) topics discussed per appointment. There was a statistically significant difference found between transmen and transwomen on number of interventions [31 (67%) vs 15 (45%), P = 0.048]. Conclusion The pharmacist in this study had the opportunity to bridge gaps in access to care to healthcare providers by initiating and managing medications, providing thorough education, and referring patients to further resources. This study affirms the accessibility and role of a psychiatric pharmacist on the interdisciplinary team caring for lesbian, gay, bisexual, transgender, queer or questioning, and more (LGBTQ+) patients.
引用
收藏
页码:1278 / 1283
页数:6
相关论文
共 25 条
  • [1] The Role of a Psychiatric Pharmacist in College Health
    Caley, Charles F.
    Webber, Donna
    Kurland, Michael
    Holmes, Paula
    JOURNAL OF AMERICAN COLLEGE HEALTH, 2010, 58 (04) : 393 - 396
  • [2] Redefining the Role of the Pharmacist: Medication Therapy Management
    Hilsenrath, Peter
    Woelfel, Joseph
    Shek, Allen
    Ordanza, Katrina
    JOURNAL OF RURAL HEALTH, 2012, 28 (04) : 425 - 430
  • [3] Pharmacist's Role in Improving Medication Adherence in Transplant Recipients With Comorbid Psychiatric Disorders
    Khorassani, Farah
    Tellier, Shannon
    Tsapepas, Demetra
    JOURNAL OF PHARMACY PRACTICE, 2019, 32 (05) : 568 - 578
  • [4] Peripartum mental health and the role of the pharmacist: A scoping review
    Urslak, Randilynne
    Evans, Charity
    Nakhla, Nardine
    Marrie, Ruth Ann
    McConnell, Brie M.
    Maxwell, Colleen J.
    RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY, 2023, 19 (09) : 1243 - 1255
  • [5] Pharmacist interventions in medication adherence in patients with mental health disorders: a scoping review
    Syrnyk, Matthew
    Glass, Beverley
    INTERNATIONAL JOURNAL OF PHARMACY PRACTICE, 2023, 31 (05) : 449 - 458
  • [6] Role of pharmacist in the management of Hansen's Disease: A scoping review
    Duarte, Elza Cristina de Oliveira
    Santiago, Nathania Rodrigues
    Visacri, Marilia Berlofa
    Lima, Tacio de Mendonca
    EXPLORATORY RESEARCH IN CLINICAL AND SOCIAL PHARMACY, 2023, 12
  • [7] Autonomous Medication Management as a program for political subjects in mental health
    Cavalheiro, Fernanda dos Santos
    de Azambuja, Marcos Adegas
    QUADERNOS DE PSICOLOGIA, 2020, 22 (01):
  • [8] Evaluation of the Addition of Pharmacist Management to a Medication Assistance Program in Patients with Hypertension and Diabetes Resistant to Usual Care
    Smith, Amy Metcalfe
    Hamann, Gale L.
    Campbell, Jennifer D.
    Sprabery, Laura R.
    JOURNAL OF PHARMACY PRACTICE, 2022, 35 (04) : 606 - 611
  • [9] An analysis of the impact on total cost of care within a pharmacist-led comprehensive medication management program
    Earby, Julie Anne
    Jenkins, Tiffany Nicole
    Johnson, Abigail Marie
    Marchwinski, Victoria Dianne
    Schmidt, Devin Marie
    JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, 2024, 7 (10): : 984 - 995
  • [10] Medication management for community palliative care patients and the role of a specialist palliative care pharmacist: A qualitative exploration of consumer and health care professional perspectives
    Kuruvilla, Lisha
    Weeks, Greg
    Eastman, Peter
    George, Johnson
    PALLIATIVE MEDICINE, 2018, 32 (08) : 1369 - 1377